Tammy Auyeung, DDS | |
2419 Ocean Ave, San Francisco, CA 94127-2623 | |
(415) 333-4232 | |
Not Available |
Full Name | Tammy Auyeung |
---|---|
Gender | Female |
Speciality | Dentist - General Practice |
Location | 2419 Ocean Ave, San Francisco, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013479161 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1223G0001X | Dentist - General Practice | 105311 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Tammy Auyeung, DDS 2651 35th Ave, San Francisco, CA 94116-2813 Ph: (415) 968-5550 | Tammy Auyeung, DDS 2419 Ocean Ave, San Francisco, CA 94127-2623 Ph: (415) 333-4232 |
News Archive
Because of the significant benefit found in combining the targeted drug ibrutinib with standard chemotherapy for relapsed chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), an interim analysis has closed the international HELIOS phase III clinical trial.
The Secretary of Health and Human Services has listed the GE-MERS National Patient Safety Organization as part of the Agency for Healthcare Research and Quality's Patient Safety Organization program. With this federal certification, GE Healthcare Performance Solutions joins leading healthcare organizations across the U.S. working to minimize risks in patient care.
The protease inhibitor lopinavir - the primary component of Abbott Laboratories' antiretroviral drug Kaletra - selectively killed the human papillomavirus in laboratory tests, according to a study scheduled to be published next month in the journal Anti-Viral Therapy.
As cash-strapped U.S. cities and states struggle to address gaping budget holes, a long-honored benefit for public-sector workers has come into the cross-hairs of budget cutters: retiree health insurance. A growing number of states and cities are eliminating or reducing health coverage for retirees, a benefit that has long fallen by the wayside for most private-sector workers.
AFFiRiS AG will focus its Alzheimer's vaccine program on one product candidate at an unexpectedly early stage of development: the vaccine candidate AD02 is planned to enter into Phase II clinical trial early in 2010. This decision by the company immediately follows the completion of two Phase I trials with the candidates AD01 and AD02. The company based its fast decision on the first interim analysis of the secondary endpoints at the six month time point.
› Verified 7 days ago
Dr. Cuong Chi Ho, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 156 W Portal Ave # C, San Francisco, CA 94127 Phone: 415-564-2200 Fax: 415-520-6737 | |
Dr. Laila Kafi, D.M.D. Dentist Medicare: Not Enrolled in Medicare Practice Location: 2827 Franklin St, San Francisco, CA 94123 Phone: 415-776-1900 Fax: 415-776-5504 | |
Dr. Ephraim W Aklilu, Dentist Medicare: Not Enrolled in Medicare Practice Location: 58 W Portal Ave # 106, San Francisco, CA 94127 Phone: 510-914-6903 | |
Dr. Kapil Deepak Kirpekar, DDS Dentist Medicare: Medicare Enrolled Practice Location: 2494 Mission St, San Francisco, CA 94110 Phone: 415-873-8225 | |
Dr. Anh T Nguyen, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 2295 California St Apt 37, San Francisco, CA 94115 Phone: 408-209-4711 | |
Alireza Khoshvaghti, DDS Dentist Medicare: Medicare Enrolled Practice Location: 220 Montgomery St Ste 483, San Francisco, CA 94104 Phone: 415-398-6344 | |
Joseph Yang, MD, DMD, MBE Dentist Medicare: Medicare Enrolled Practice Location: 99 W Portal Ave, San Francisco, CA 94127 Phone: 415-661-6006 |